0001209191-17-048420.txt : 20170810 0001209191-17-048420.hdr.sgml : 20170810 20170810162012 ACCESSION NUMBER: 0001209191-17-048420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170808 FILED AS OF DATE: 20170810 DATE AS OF CHANGE: 20170810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LASEZKAY GEORGE M CENTRAL INDEX KEY: 0001020514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 171021697 MAIL ADDRESS: STREET 1: 1301 SECOND AVE., SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-08 0 0001539029 Clearside Biomedical, Inc. CLSD 0001020514 LASEZKAY GEORGE M C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Stock Option (right to buy) 7.96 2017-08-08 4 A 0 22500 0.00 A 2027-08-07 Common Stock 22500 22500 D This option will vest and become exercisable in 36 equal monthly installments through August 8, 2020, subject to the reporting person's continuous service as of such vesting dates. /s/ Brian F. Leaf, Attorney-in-Fact 2017-08-10